Abstract | INTRODUCTION: METHODS: We synthesized four NTR1-targeted conjugates with spacer lengths from 0 to 9 atoms (null (N0), β-Ala- OH (N1), 5-Ava- OH (N2), and 8-Aoc- OH (N3)) between the DOTA and the pharmacophore. In vitro competitive binding, internalization and efflux studies were performed on all four NT analogs. Based on these findings, metabolism studies were carried out on our best performing conjugate, (177)Lu-N1. Lastly, in vivo biodistribution and SPECT/CT imaging studies were performed using (177)Lu-N1 in an HT-29 xenograft mouse model. RESULTS: As shown in the competitive binding assays, the NT analogs with different spacers (N1, N2 and N3) exhibited lower IC50 values than the NT analog without a spacer (N0). Furthermore, N1 revealed higher retention in HT-29 cells with more rapid internalization and slower efflux than the other NT analogs. In vivo biodistribution and SPECT/CT imaging studies of (177)Lu-N1 demonstrated excellent accumulation (3.1 ± 0.4%ID/g) in the NTR1-positive tumors at 4h post-administration. CONCLUSIONS: The DOTA chelation system demonstrated some modest steric inhibition of the pharmacophore. However, the insertion of a 4-atom hydrocarbon spacer group restored optimal binding affinity of the analog. The in vivo assays indicated that (177)Lu-N1 could be used for imaging and radiotherapy of NTR1-positive tumors.
|
Authors | Yinnong Jia, Wen Shi, Zhengyuan Zhou, Nilesh K Wagh, Wei Fan, Susan K Brusnahan, Jered C Garrison |
Journal | Nuclear medicine and biology
(Nucl Med Biol)
Vol. 42
Issue 11
Pg. 816-23
(Nov 2015)
ISSN: 1872-9614 [Electronic] United States |
PMID | 26302836
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
- Chelating Agents
- Peptide Fragments
- Receptors, Neurotensin
- neurotensin type 1 receptor
- Neurotensin
|
Topics |
- Animals
- Binding, Competitive
- Cell Line, Tumor
- Chelating Agents
(chemistry)
- Drug Stability
- HT29 Cells
- Humans
- Isotope Labeling
- Mice
- Neurotensin
(chemistry, metabolism, pharmacokinetics)
- Peptide Fragments
(chemistry)
- Protein Transport
- Receptors, Neurotensin
(metabolism)
- Tissue Distribution
- Tomography, Emission-Computed, Single-Photon
- X-Ray Microtomography
|